GVK Biosciences Pvt. Ltd. announced that it has entered into a research agreement with U.S.-based Wyeth Pharmaceuticals to discover drug candidates. Under the agreement, GVK Biosciences will receive an initial upfront payment, as well as payments based on the achievement of certain research milestones, the Indian pharmaceutical research services company said in a statement. The statement didn't elaborate on the amount of the payments.
GVK Biosciences will be responsible for identifying drug candidates, which will be transferred to Wyeth to advance towards clinical studies, the statement added.
GVK Biosciences will be responsible for identifying drug candidates, which will be transferred to Wyeth to advance towards clinical studies, the statement added.
